Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ·Healthcare·Biotechnology
$316.29
+0.88%
Mkt Cap $6.43B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (26 analysts)
$339.43
Range $326.00 – $358.00
Implied Upside
+7.3%
Consensus $339.43 vs current $316.29